AtriCure, Inc. (ATRC) Current Ratio
- Current ratio · latest quarter: Value 4.22×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 4.22× | Current assets / current liabilities. $345.53M ÷ $81.92M ≈ 4.22× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 345.53M USD | Assets, Current |
| Current obligations | 81.92M USD | Liabilities, Current |
| Cash and equivalents | 167.79M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 79.98M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 83.92M USD | Inventory, Net |
| Payables | 35.85M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $345.53M | $81.92M | $167.79M | (m) | $79.98M | $83.92M | $35.85M | (m) | 4.22× |
| 2026-03-31 | $313.69M | $73.19M | $146.16M | (m) | $71.31M | $81.14M | $30.56M | (m) | 4.29× |
| 2025-12-31 | $322.52M | $81.52M | $167.43M | (m) | $66.65M | $78.49M | $25.31M | (m) | 3.96× |
| 2025-09-30 | $301.11M | $77.84M | $147.87M | (m) | $62.98M | $78.95M | $25.47M | (m) | 3.87× |
| 2025-06-30 | $271.26M | $68.84M | $117.80M | (m) | $66.00M | $76.34M | $25.68M | (m) | 3.94× |
| 2025-03-31 | $251.48M | $61.22M | $99.89M | (m) | $63.32M | $74.91M | $25.18M | (m) | 4.11× |
| 2024-12-31 | $267.83M | $73.42M | $122.72M | (m) | $60.34M | $75.33M | $25.03M | (m) | 3.65× |
| 2024-09-30 | $269.29M | $74.43M | $130.34M | (m) | $54.91M | $76.55M | $31.74M | (m) | 3.62× |
| 2024-06-30 | $252.85M | $61.23M | $106.03M | (m) | $55.57M | $73.65M | $26.67M | (m) | 4.13× |
| 2024-03-31 | $245.22M | $61.25M | $64.97M | (m) | $55.32M | $71.94M | $28.99M | (m) | 4.00× |
| 2023-12-31 | $266.25M | $74.57M | $84.31M | (m) | $52.50M | $67.90M | $27.35M | (m) | 3.57× |
| 2023-09-30 | $252.72M | $82.54M | $80.60M | (m) | $51.53M | $61.89M | $24.54M | (m) | 3.06× |
| 2023-06-30 | $237.97M | $71.41M | $67.24M | (m) | $48.36M | $55.41M | $23.71M | (m) | 3.33× |
| 2023-03-31 | $238.32M | $62.47M | $77.34M | (m) | $45.66M | $48.85M | $23.56M | (m) | 3.81× |
| 2022-12-31 | $215.21M | $58.39M | $58.10M | (m) | $42.69M | $45.93M | $19.90M | (m) | 3.69× |
| 2022-09-30 | $212.28M | $57.60M | $48.82M | (m) | $41.47M | $43.95M | $24.41M | (m) | 3.69× |
| 2022-06-30 | $206.17M | $56.32M | $54.56M | (m) | $41.49M | $41.29M | $23.72M | (m) | 3.66× |
| 2022-03-31 | $199.61M | $47.38M | $28.14M | (m) | $40.88M | $40.76M | $20.29M | (m) | 4.21× |
| 2021-12-31 | $196.08M | $56.45M | $43.65M | (m) | $33.02M | $38.96M | $18.60M | (m) | 3.47× |
| 2021-09-30 | $195.71M | $53.95M | $39.89M | (m) | $33.50M | $38.59M | $17.53M | (m) | 3.63× |
| 2021-06-30 | $235.94M | $67.43M | $67.62M | (m) | $33.84M | $37.61M | $16.50M | (m) | 3.50× |
| 2021-03-31 | $298.30M | $58.46M | $85.38M | (m) | $29.74M | $36.14M | $15.46M | (m) | 5.10× |
| 2020-12-31 | $306.74M | $49.14M | $41.94M | (m) | $23.15M | $35.03M | $12.74M | (m) | 6.24× |
| 2020-09-30 | $296.21M | $44.75M | $33.38M | (m) | $25.45M | $34.33M | $13.55M | (m) | 6.62× |
| 2020-06-30 | $292.03M | $38.05M | $88.52M | (m) | $22.89M | $32.81M | $12.47M | (m) | 7.67× |
| 2020-03-31 | $127.02M | $39.07M | $21.77M | (m) | $22.13M | $32.06M | $17.30M | (m) | 3.25× |
| 2019-12-31 | $143.16M | $49.92M | $28.48M | (m) | $28.05M | $29.41M | $14.95M | (m) | 2.87× |
| 2019-09-30 | $137.85M | $44.28M | $33.18M | (m) | $26.80M | $27.79M | $13.97M | (m) | 3.11× |
| 2019-06-30 | $146.53M | $39.43M | $25.25M | (m) | $27.95M | $24.43M | $12.59M | (m) | 3.72× |
| 2019-03-31 | $155.02M | $35.47M | $20.72M | (m) | $26.66M | $24.12M | $10.38M | (m) | 4.37× |
| 2018-12-31 | $174.67M | $40.22M | $32.23M | (m) | $25.20M | $22.48M | $9.66M | (m) | 4.34× |
| 2018-09-30 | $88.43M | $33.74M | $18.00M | (m) | $23.29M | $22.26M | $10.59M | (m) | 2.62× |
| 2018-06-30 | $86.77M | $27.42M | $13.87M | (m) | $24.89M | $21.68M | $9.67M | (m) | 3.16× |
| 2018-03-31 | $84.77M | $26.87M | $21.23M | (m) | $22.32M | $22.57M | $11.58M | (m) | 3.15× |
| 2017-12-31 | $82.26M | $31.90M | $21.81M | (m) | $23.08M | $22.45M | $12.43M | (m) | 2.58× |
| 2017-09-30 | $82.15M | $36.07M | $19.44M | (m) | $22.58M | $22.57M | $10.79M | (m) | 2.28× |
| 2017-06-30 | $81.11M | $31.70M | $21.01M | (m) | $23.11M | $19.94M | $11.70M | (m) | 2.56× |
| 2017-03-31 | $79.11M | $28.41M | $19.15M | (m) | $21.66M | $18.84M | $11.26M | (m) | 2.78× |
| 2016-12-31 | $85.72M | $28.83M | $24.21M | (m) | $21.09M | $17.66M | $10.67M | (m) | 2.97× |
| 2016-09-30 | $84.41M | $26.49M | $16.11M | (m) | $21.07M | $18.98M | $10.99M | (m) | 3.19× |
| 2016-06-30 | $86.47M | $25.19M | $19.92M | (m) | $21.35M | $19.31M | $11.93M | (m) | 3.43× |
| 2016-03-31 | $65.39M | $26.19M | $20.77M | (m) | $19.45M | $19.02M | $12.80M | (m) | 2.50× |
| 2015-12-31 | $74.75M | $31.59M | $23.76M | (m) | $19.41M | $17.66M | $12.74M | (m) | 2.37× |
| 2015-09-30 | $84.11M | $39.06M | $28.71M | (m) | $16.64M | $16.57M | $11.17M | (m) | 2.15× |
| 2015-06-30 | $90.74M | $30.14M | $29.99M | (m) | $17.59M | $16.07M | $9.34M | (m) | 3.01× |
| 2015-03-31 | $93.42M | $24.63M | $23.56M | (m) | $19.79M | $15.11M | $9.66M | (m) | 3.79× |
| 2014-12-31 | $93.51M | $25.64M | $28.38M | (m) | $17.56M | $14.26M | $7.62M | (m) | 3.65× |
| 2014-09-30 | $90.72M | $21.89M | $35.53M | (m) | $15.18M | $14.56M | $7.79M | (m) | 4.14× |
| 2014-06-30 | $92.77M | $16.88M | $41.98M | (m) | $15.06M | $12.67M | $7.52M | (m) | 5.50× |
| 2014-03-31 | $107.25M | $16.01M | $68.64M | (m) | $14.71M | $11.08M | $7.92M | (m) | 6.70× |
| 2013-12-31 | $52.49M | $26.71M | $14.89M | (m) | $13.65M | $10.21M | $8.61M | (m) | 1.96× |
| 2013-09-30 | $48.56M | $16.27M | $25.82M | (m) | $11.03M | $7.06M | $5.72M | (m) | 2.98× |
| 2013-06-30 | $53.47M | $13.40M | $31.04M | (m) | $11.34M | $6.03M | $5.20M | (m) | 3.99× |
| 2013-03-31 | $54.36M | $12.69M | $30.78M | (m) | $11.13M | $5.69M | $5.43M | (m) | 4.28× |
| 2012-12-31 | $28.54M | $12.21M | $7.75M | (m) | $9.95M | $5.72M | $5.10M | (m) | 2.34× |
| 2012-09-30 | $30.12M | $11.60M | $8.20M | (m) | $9.39M | $6.88M | $4.79M | (m) | 2.60× |
| 2012-06-30 | $31.43M | $11.74M | $8.66M | (m) | $10.38M | $6.49M | $4.85M | (m) | 2.68× |
| 2012-03-31 | $33.11M | $11.82M | $11.42M | (m) | $9.72M | $7.04M | $5.23M | (m) | 2.80× |
| 2011-12-31 | $31.19M | $10.81M | $9.76M | (m) | $9.51M | $6.56M | $5.27M | (m) | 2.89× |
| 2011-09-30 | $31.74M | $9.97M | $3.43M | (m) | $8.85M | $6.54M | $4.83M | (m) | 3.18× |
| 2011-06-30 | $33.05M | $10.60M | $4.11M | (m) | $9.90M | $6.01M | $5.18M | (m) | 3.12× |
| 2010-12-31 | $30.65M | $13.04M | $4.23M | (m) | $9.48M | $5.68M | $4.51M | (m) | 2.35× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |